Amanda Hayden is an Executive Director of Clinical Operations at Eledon Pharmaceuticals, and has worked for over 20 years in the clinical operations field. Amanda started her career as a CRA with a small CRO, progressing to Lead CRA and Project and Program Management roles at Antigenics (now Agenus) and Millennium Pharmaceuticals (now Takeda). She then transitioned into Clinical Leadership positions at Lantheus Medical Imaging, and at Alkermes, where Amanda spent 8 years overseeing Study Start Up, Clinical Compliance, Clinical Systems and Disclosure and Technical Solutions. She has extensive prior monitoring and project management experience, with more than 10 years focused on Oncology trials. More recently, Amanda has spent significant time dedicated to large scale trial start-up, including global trial submissions and study launches in approximately 20 countries, as well as in overseeing ICH E6 R2 implementation and Inspection Readiness initiatives.